Table 1.
Demographic, medical, and COVID-19 characteristics of cancer survivors (N = 493)
| Variable | Mean ± SD or n (%) |
|---|---|
| Demographic | |
| Age (years) | 48.7 ± 15.8 |
| Gender | |
| Women | 347 (70.4) |
| Men | 143 (29.0) |
| Self-identify | 2 (0.4) |
| Ethnicity | |
| White | 443 (89.9) |
| Asian | 17 (3.4) |
| Latin American | 10 (2.0) |
| Black | 8 (1.6) |
| Other | 10 (2.0) |
| Education | |
| Some/completed high school | 89 (18.1) |
| Some/completed university/college/graduate | 403 (81.7) |
| Employment | |
| Full Time | 179 (36.3) |
| Part-time | 105 (21.3) |
| Unemployed | 209 (42.4) |
| Medical | |
| Cancer type | |
| Breast | 143 (29.0) |
| Urologic | 72 (14.6) |
| Hematologic | 59 (12.0) |
| Gynecologic | 57 (11.6) |
| Skin | 45 (9.1) |
| Thyroid | 24 (4.9) |
| Colorectal | 21 (4.3) |
| Lung | 11 (2.2) |
| Head and neck | 10 (2.0) |
| Other | 49 (9.9) |
| Months since diagnosis | 87.1 ± 81.9 |
| Disease stage | |
| Localized | 399 (80.9) |
| Metastatic | 78 (15.8) |
| Unsure | 14 (2.8) |
| Months since last treatment | 58.8 ± 77.5 |
| COVID-19 variables | |
| Geographic location | |
| UK | 187 (37.9) |
| USA | 113 (22.9) |
| Canada | 103 (20.9) |
| European Union country | 43 (8.7) |
| Australia | 7 (1.4) |
| South Africa | 7 (1.4) |
| Other | 33 (6.7) |
| Government-mandated prevention measuresa | |
| Complete lockdown | 29 (5.9) |
| Mandatory/suggested stay-at-home | 261 (52.9) |
| Physical distancing | 465 (94.3) |
| Other | 78 (15.8) |
| None | 4 (0.8) |
| Personal prevention measuresa | |
| Physical distancing | 445 (90.3) |
| Self-isolate | 138 (28.0) |
| Other | 22 (4.5) |
| None | 14 (2.8) |
aCould indicate more than one response